CYCLO THERAPEUTICS INC (CYTH) Stock Analyst Earnings Estimates
NASDAQ:CYTH - Nasdaq - US23254X2018 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.59M 76.67% | 1.38M -13.21% | 1.076M -22.00% | 985.657K -8.43% | 1.227M 24.49% | 14.824M 1,108.15% | |
| EBITDA YoY % growth | -14.27M -59.44% | -15.6M -9.32% | -20.031M -28.40% | N/A | N/A | N/A | |
| EBIT YoY % growth | -14.29M -59.49% | -15.62M -9.31% | -20.05M -28.36% | -23.2M -15.71% | -27.616M -19.04% | -22.84M 17.29% | |
| Operating Margin | -898.74% | -1,131.88% | -1,862.68% | -2,353.75% | -2,250.71% | -154.08% | |
| EPS YoY % growth | -2.30 39.71% | -1.83 20.43% | N/A 13.05% | -0.69 56.84% | -0.68 1.49% | -0.37 44.97% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 55.86% | -0.19 -25.80% | -0.20 2.86% | -0.18 33.89% | -0.19 -16.33% |
| Revenue Q2Q % growth | 328.44K 5.47% | 153K -24.26% | 102K -17.07% | 357K 53.22% | 255K -22.36% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.291M -11.49% | -5.61M -9.80% | -6.222M -10.40% | -6.018M 27.40% | -6.222M 1.10% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.27 24.37% | -0.16 | -0.11 | -68.96% |
| Q2 2024 Q2Q % growth | -0.21 36.36% | -0.16 | -0.05 | -32.83% |
| Q1 2024 Q2Q % growth | -0.15 67.39% | -0.21 | 0.06 | 28.26% |
| Q4 2023 Q2Q % growth | 36.03% | -0.38 | % | |
| Q3 2023 Q2Q % growth | 28.60% | -0.36 | % | |
| Q2 2023 Q2Q % growth | -0.33 19.51% | -0.45 | 0.12 | 26.47% |
| Q1 2023 Q2Q % growth | -0.46 -39.39% | -0.43 | -0.03 | -7.38% |
| Q4 2022 Q2Q % growth | -0.59 -55.26% | -0.26 | -0.33 | -131.37% |
| Q3 2022 Q2Q % growth | -0.50 16.67% | -0.54 | 0.04 | 7.51% |
| Q2 2022 Q2Q % growth | -0.41 26.79% | -0.50 | 0.09 | 17.97% |
| Q1 2022 Q2Q % growth | -0.33 56.58% | -0.49 | 0.16 | 32.60% |
| Q4 2021 Q2Q % growth | -0.38 76.25% | -0.53 | 0.15 | 28.36% |
| Q3 2021 Q2Q % growth | -0.60 | -0.68 | 0.08 | 12.20% |
| Q2 2021 Q2Q % growth | -0.56 | -0.78 | 0.22 | 27.76% |
| Q1 2021 Q2Q % growth | -0.76 | -0.78 | 0.02 | 1.96% |
| Q4 2020 Q2Q % growth | -1.60 20.00% | -0.34 | -1.26 | -375.34% |
| Q4 2019 Q2Q % growth | -2.00 | -1.02 | -0.98 | -96.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 233K -52.97% | 299.88K | -66.88K | -22.30% |
| Q2 2024 Q2Q % growth | 123K 5.13% | 272.85K | -149.85K | -54.92% |
| Q1 2024 Q2Q % growth | 202K 32.89% | 384.203K | -182.203K | -47.42% |
| Q4 2023 Q2Q % growth | 311.4K 63.89% | 454.92K | -143.52K | -31.55% |
| Q3 2023 Q2Q % growth | 495.48K 10.11% | 437.58K | 57.9K | 13.23% |
| Q2 2023 Q2Q % growth | 117K -78.33% | 403.92K | -286.92K | -71.03% |
| Q1 2023 Q2Q % growth | 152K -20.00% | 387.6K | -235.6K | -60.78% |
| Q4 2022 Q2Q % growth | 190K -67.80% | 654.84K | -464.84K | -70.99% |
| Q3 2022 Q2Q % growth | 450K 12.50% | 630.36K | -180.36K | -28.61% |
| Q2 2022 Q2Q % growth | 540K 125.00% | 582.42K | -42.42K | -7.28% |
| Q1 2022 Q2Q % growth | 190K -47.22% | 557.94K | -367.94K | -65.95% |
| Q4 2021 Q2Q % growth | 590K 293.33% | 400.86K | 189.14K | 47.18% |
| Q3 2021 Q2Q % growth | 400K 81.82% | 389.64K | 10.36K | 2.66% |
| Q2 2021 Q2Q % growth | 240K 14.29% | 367.2K | -127.2K | -34.64% |
| Q1 2021 Q2Q % growth | 360K 9.09% | 363.369K | -3.369K | -0.93% |
| Q4 2020 Q2Q % growth | 150K -34.78% | 255K | -105K | -41.18% |
| Q3 2020 Q2Q % growth | 220K -24.14% | % | ||
| Q2 2020 Q2Q % growth | 210K -22.22% | % | ||
| Q1 2020 Q2Q % growth | 330K 50.00% | % | ||
| Q4 2019 Q2Q % growth | 230K | 255K | -25K | -9.80% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 16.24% | 0% | 0% |
| Revenue | 0% | -12.38% | 0% | 0% |